SynthesisDie Ophthalmologie2025
[Risk factors for age-related macular degeneration : Lessons learned from current data].
Synthesis in Die Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdentifying risk factors for age-related macular degeneration (AMD) is crucial for patient counseling and the development of potential prevention strategies.
objectivesThis study summarizes the current epidemiological evidence on AMD risk factors, analyzes their clinical relevance, and discusses potential preventive measures. MATERIALS AND
methodsA systematic literature review was conducted to assess demographic, genetic, and modifiable risk factors for AMD, including smoking, diet, and physical activity.
resultsAge is the strongest risk factor for early and advanced AMD. Genetic predisposition also plays a critical role, particularly from genetic variants in the complement and lipid metabolism pathways and extracellular matrix. Modifiable factors such as smoking, dietary habits, and physical activity significantly influence the risk of AMD. Recent studies further suggest a potentially beneficial effect of medication intake, such as metformin and statins.
conclusionEpidemiological data indicate that smoking cessation, adherence to a Mediterranean diet, and regular physical activity are associated with a reduced risk of AMD over time. These factors should be integral to patient counseling. The continued extension of longitudinal study data will be key to refining individual risk profiles and optimizing prevention strategies.
Indexed as
Identifiers
40512437What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.